Focused Wealth Management, Inc Voyager Therapeutics, Inc. Transaction History

Focused Wealth Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$4.82 - $10.09 $48,200 - $100,900	-10,000 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$2.47 - $5.55 $24,700 - $55,500	10,000 New	10,000 $27,000
Q3 2021 Oct 12, 2021	SELL	$2.63 - $4.12 $65,750 - $103,000	-25,000 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$3.94 - $5.44 $98,500 - $136,000	25,000 New	25,000 $103,000
Q4 2019 Jan 21, 2020	SELL	$12.82 - $16.85 $12,820 - $16,850	-1,000 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$16.76 - $23.92 $16,760 - $23,920	-1,000 Reduced 50.0%	1,000 $20,000
Q1 2018 May 07, 2018	SELL	$16.16 - $31.31 $32,320 - $62,620	-2,000 Reduced 50.0%	2,000 $38,000
Q4 2017 Feb 13, 2018	BUY	$12.26 - $25.88 $24,520 - $51,760	2,000 Added 100.0%	4,000 $66,000
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $16,740 - $41,180	2,000	2,000 $41,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $222M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.